Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Anim Reprod Sci ; 153: 8-12, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25578505

RESUMEN

This study characterizes the physiological and morphological changes related to partial luteolysis in bovine corpus luteum (CL) after challenges with sub-doses of cloprostenol sodium on Day 6 (D6) of the estrous cycle. Cows (n = 12/treatment) were treated as follows: Control (2 mL, saline, i.m.); 2XPGF (two treatments i.m. 500 µg of cloprostenol sodium 2 h apart) and 1/6PGF (83.3 µg of cloprostenol sodium, i.m., once). Plasma progesterone (P4) concentration, CL volume and blood flow were measured immediately before the treatments, then every 8 h (h) for 48 h. In the Control, P4 concentrations were higher at 48 h than at 0 h. P4 decreased 8h after 2XPGF treatment (P < 0.05), and remained low until the end of the trial. P4 decreased in 1/6PGF between 8 and 16 h (P < 0.05), then began to rebound at 24 h. Luteal volume was higher in Controls at 48 h than at 0 h. Under 1/6PGF, luteal volume decreased at 24 h (P < 0.05) and began to rebound at 32 h. Luteal volume and blood flow were reduced starting at 24 and 32 h, respectively, after 2XPGF treatment (P < 0.05). In this study, we were able to describe the partial luteolysis phenomenon, induced by a treatment of a D6CL with cloprostenol sub-dose.


Asunto(s)
Bovinos , Cloprostenol/farmacología , Cuerpo Lúteo/anatomía & histología , Cuerpo Lúteo/efectos de los fármacos , Luteolíticos/farmacología , Animales , Cuerpo Lúteo/irrigación sanguínea , Cuerpo Lúteo/diagnóstico por imagen , Relación Dosis-Respuesta a Droga , Femenino , Fase Luteínica/sangre , Fase Luteínica/efectos de los fármacos , Luteólisis/efectos de los fármacos , Tamaño de los Órganos/efectos de los fármacos , Progesterona/sangre , Flujo Sanguíneo Regional/efectos de los fármacos , Ultrasonografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA